[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334153-105":59,"doc-detail-334153-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","nuclear-expression-of-dynamin-2-is-associated-with-tumor-aggressiveness-in-bladder-cancer-patients-a-bioinformatics-and-experimental-approach","Nuclear Expression of Dynamin 2 Is Associated With Tumor Aggressiveness in Bladder Cancer Patients - A Bioinformatics and Experimental Approach","","Study evaluates whether nuclear Dynamin 2 (DNM2) expression relates to clinical progression and prognosis in bladder cancer by combining bioinformatics mining with experimental validation. GEPIA2 and GENT2 analyses were used to explore DNM2 gene expression and protein–protein interaction networks, followed by pathway enrichment. Immunohistochemistry on 209 bladder cancer tissue samples showed higher DNM2 expression in tumors than adjacent normal tissue, with nuclear DNM2 correlating with grade, pT stage, invasion, recurrence, and metastasis, and predicting disease-specific survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nuclear-expression-of-dynamin-2-is-associated-with-tumor-aggressiveness-in-bladder-cancer-patients-a-bioinformatics-and-experimental-approach/334153/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nuclear-expression-of-dynamin-2-is-associated-with-tumor-aggressiveness-in-bladder-cancer-patients-a-bioinformatics-and-experimental-approach/334153.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study on DNM2 in bladder cancer?","Question",{"text":112,"@type":113},"To evaluate the clinical and prognostic value of Dynamin 2 in bladder cancer using bioinformatics analysis and experimental evaluation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was DNM2 expression investigated in the research workflow?",{"text":117,"@type":113},"Gene expression and interaction networks were analyzed using GEPIA2 and GENT2 with PPI analysis and pathway enrichment, followed by immunohistochemical testing on 209 bladder cancer samples.",{"name":119,"@type":110,"acceptedAnswer":120},"What associations were found between nuclear DNM2 expression and tumor features?",{"text":121,"@type":113},"Nuclear DNM2 expression was significantly associated with higher histological grade, advanced pT stage, muscular invasion, tumor recurrence, and distant metastasis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334153,1790182589,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Cancer Reports  \nORIGINAL ARTICLE  OPEN ACCESS   \nNuclear Expression of Dynamin 2 Is Associated With Tumor Aggressiveness in Bladder Cancer Patients:  \nA Bioinformatics and Experimental Approach  \nMahdieh Razmi1  | Leili Saeednejad Zanjani1,2 | Mandana Rahimi3 | Roya Sajed1,4 | Sadegh Safaei1,4 | Zahra Madjd1,4 | Roya Ghods1,4   \n1Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran | 2Department of Pathology and Genomic Medicine, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, USA | 3Hasheminejad Kidney Center, Pathology Department, Iran University of Medical Sciences (IUMS), Tehran, Iran | 4Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medicine Sciences (IUMS), Tehran, Iran  \nCorrespondence: Zahra Madjd ([majdjabari.z@iums.ac.ir](majdjabari.z@iums.ac.ir)) | Roya Ghods ([rghods77@yahoo.com](rghods77@yahoo.com))  \nReceived: 8 January 2024 | Revised: 10 June 2024 | Accepted: 30 June 2024  \nFunding: This work was supported by a grant from Iran University of Medical Sciences (No. 98-04-28-17448) for providing laboratory equipment.  \nKeywords: bladder cancer (BC) | bioinformatics | dynamin 2 (DNM2) | immunohistochemistry (IHC) | tissue microarray (TMA)  \nABSTRACT  \nBackground: Dynamin 2 (DNM2) is aberrantly expressed in different malignancies and exerts a function in tumor progression. Aims: This study, for the first time, aimed to evaluate the clinical and prognostic value of DNM2 in the pathophysiology of bladder cancer using bioinformatics analysis and experimental evaluation.  \nMethods and Results: We analyzed gene expression of DNM2 in bladder tumor by GEPIA2 and GENT2 platforms. Cluster subnetworks were recognized from the protein–protein interaction (PPI) network using the MCODE plugin to screen the key genes. Subsequently, the pathway enrichment analysis was evaluated. Then, the immunohistochemical examination was conducted on 209 paraffin-embedded bladder cancer samples to determine the expression pattern and clinical importance of DNM2 . Our data mining findings demonstrated dysregulation of DNM2 gene expression in bladder cancer. The results of pathway and PPI network analyses indicated that DNM2 might be involved in the development of bladder cancer by influencing various signaling pathways. Our IHC results represented remarkably higher DNM2 expression in bladder tumor samples compared to normal tissue samples adjacent to tumor. A statistically significant association was identified between DNM2 expression in the nucleus and higher histological grade (p = 0.026), advanced pT stage (p = 0.016), muscular invasion (p = 0.007), tumor recurrence (p = 0.030), and distant metastasis (p \u003C 0.001) . Moreover, the nuclear DNM2 expression was observed to have prognostic significance for disease-specific survival (DSS) using a log-rank test (p = 0.028) .  \nConclusion: These findings suggest that nuclear DNM2 expression could be a putative indicator of bladder tumor progression owing to its association with elevated cancer aggressiveness.  \n1 | Introduction  \nBladder cancer (BC) is the most common malignancy of the urinary tract worldwide, with approximately 549 000 new cases a year [1, 2] . The most frequent histological type of BC  \nis urothelial cell carcinoma, which is also called transitional cell carcinoma (TCC) [3]. Bladder tumor is clinically classified into two distinct subtypes; approximately 75% of cases possess nonmuscle-invasive BC (NMIBC), which is frequently recurrent, and 10%–30% of cases develop a progression to  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Author(s). Cancer Reports published by Wiley Periodicals LLC.  \nCancer Reports, 2024; 7:e2133 1 of 14  \n[https://doi.org/10.1002/cnr2.2133](https://doi.org/10.1002/cnr2.2133)  \nmuscle-","cbCait313MLGC4XC","https://ap.wps.com/l/cbCait313MLGC4XC","pdf",7869374,14,"English","# Abstract\n## Background\n## Methods and Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main goal of the study on DNM2 in bladder cancer?\",\"answer\":\"To evaluate the clinical and prognostic value of Dynamin 2 in bladder cancer using bioinformatics analysis and experimental evaluation.\"},{\"question\":\"How was DNM2 expression investigated in the research workflow?\",\"answer\":\"Gene expression and interaction networks were analyzed using GEPIA2 and GENT2 with PPI analysis and pathway enrichment, followed by immunohistochemical testing on 209 bladder cancer samples.\"},{\"question\":\"What associations were found between nuclear DNM2 expression and tumor features?\",\"answer\":\"Nuclear DNM2 expression was significantly associated with higher histological grade, advanced pT stage, muscular invasion, tumor recurrence, and distant metastasis.\"}]","Nuclear Expression of Dynamin 2 Is Associated With Tumor Aggressiveness in Bladder Cancer Patients - A Bioinformatics and Experimental Approach | PDF",1790005520,35]